Cargando…
Survival bias and drug interaction can attenuate cross-sectional case-control comparisons of genes with health outcomes. An example of the kinesin-like protein 6 (KIF6) Trp719Arg polymorphism and coronary heart disease
BACKGROUND: Case-control studies typically exclude fatal endpoints from the case set, which we hypothesize will substantially underestimate risk if survival is genotype-dependent. The loss of fatal cases is particularly nontrivial for studies of coronary heart disease (CHD) because of significantly...
Autores principales: | Williams, Paul, Pendyala, Lakshmana, Superko, Robert |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3078850/ https://www.ncbi.nlm.nih.gov/pubmed/21435211 http://dx.doi.org/10.1186/1471-2350-12-42 |
Ejemplares similares
-
The Trp719Arg polymorphism of the KIF6 gene and coronary heart disease risk: systematic review and meta-analysis
por: Ruiz-Ramos, David, et al.
Publicado: (2015) -
Meta-Analyses of KIF6 Trp719Arg in Coronary Heart Disease and Statin Therapeutic Effect
por: Peng, Ping, et al.
Publicado: (2012) -
KIF6 p.Trp719Arg Testing to Assess Risk of Coronary Artery Disease and/or Statin Response
por: Allingham-Hawkins, Diane, et al.
Publicado: (2010) -
KIF6 Trp719Arg Genetic Variant Increases Risk for Thoracic Aortic Dissection
por: Velasco, Juan J., et al.
Publicado: (2023) -
Impact of 719Trp>Arg Polymorphism of KIF 6 Gene on Contrast Induced Nephropathy in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention
por: Barbieri, Lucia, et al.
Publicado: (2022)